Alto Neuroscience (ANRO) Exchange Rate Effect (2023 - 2026)
Alto Neuroscience's (ANRO) quarterly Exchange Rate Effect came in at -$16000.0 in Q1 2026, up 27.27% year-on-year from -$12571.4 in Q1 2025, and down 1500.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Alto Neuroscience (ANRO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Alto Neuroscience has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$16000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$16000.0, up 27.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24000.0 (up 14.29% YoY), and the FY2025 annual result was -$30000.0, down 172.73% from the prior year.
- Exchange Rate Effect came in at -$16000.0 for Q1 2026 at Alto Neuroscience, down from -$1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $18000.0 in Q3 2023 to a low of -$22000.0 in Q1 2025.
- The 4-year median for Exchange Rate Effect is -$5000.0 (2024), against an average of -$5000.0.
- Across the five-year window, Exchange Rate Effect surged 73.68% in 2024 and sank 340.0% in 2025, its largest moves.
- Alto Neuroscience's Exchange Rate Effect stood at $4000.0 in 2023, then surged by 50.0% to $6000.0 in 2024, then slumped by 116.67% to -$1000.0 in 2025, then slumped by 1500.0% to -$16000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$16000.0 (Q1 2026), -$1000.0 (Q4 2025), and -$4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |